• Applied Cancer Research with Doxorubicin Hydrochloride: Prot

  2026-07-17

  Doxorubicin hydrochloride (Adriamycin HCl) anchors cancer chemotherapy research and cardiotoxicity models as a gold-standard, reproducible agent. This article bridges advanced experimental workflows, recent breakthroughs in cardioprotective assay design, and troubleshooting strategies for robust, translational results.

• Epacadostat (INCB024360) in Immune Metabolism: Precision Too

  2026-07-17

  Delve into the scientific foundations of Epacadostat (INCB024360) as a selective IDO1 inhibitor, highlighting its role in modulating immune metabolism and reversing tumor-induced immune tolerance. This article integrates insights from recent phenomics research, offering practical guidance for advanced immuno-oncology workflows.

• KU-55933: ATM Kinase Inhibitor for Robust DNA Damage Respons

  2026-07-16

  KU-55933, a highly selective ATM kinase inhibitor from APExBIO, empowers scientists to dissect DNA damage signaling and cell cycle arrest with precision. Its nanomolar potency and reliable solubility make it a gold standard for both cancer research and advanced iPSC-based platforms.

• Beclin1 Deficiency Attenuates DOX-Induced Liver Injury via F

  2026-07-16

  This study delineates a novel mechanistic role for Beclin1 in promoting ferroptosis and autophagy during doxorubicin-induced liver injury. By demonstrating that Beclin1 deficiency and DHODH overexpression reduce hepatic oxidative stress and injury, the research highlights potential therapeutic strategies for mitigating chemotherapy-induced hepatotoxicity.

• Pharmacokinetics and Efficacy of Tiamulin Against M. gallise

  2026-07-15

  This article reviews a pivotal study defining the pharmacokinetic/pharmacodynamic (PK/PD) relationship of Tiamulin in a chicken model of Mycoplasma gallisepticum infection. The findings clarify optimal dosing strategies and provide a scientific foundation for effective veterinary antibiotic use and resistance mitigation.

• CNQX in Neurophysiology: Dissecting AMPA/Kainate Signaling P

  2026-07-15

  Explore how CNQX, a potent glutamatergic neurotransmission inhibitor, enables advanced mechanistic studies of AMPA and kainate receptors in the central nervous system. This article bridges technical detail with practical guidance for neuroscience research, offering a unique, evidence-driven perspective.

• Plk1 Phosphorylation of p31comet Controls Mitotic Checkpoint

  2026-07-14

  This study uncovers how Polo-like kinase 1 (Plk1) directly regulates p31comet function via phosphorylation at S102, suppressing its ability to disassemble mitotic checkpoint complexes (MCC). These findings clarify a key mechanism safeguarding mitotic fidelity and provide a foundation for further exploration of cell cycle control and genome stability.

• Translational Leverage: Mechanistic Insight via DiscoveryPro

  2026-07-14

  This thought-leadership article explores how the DiscoveryProbe™ Bioactive Compound Library Plus (SKU: L1022P) transforms translational research by bridging high-throughput screening with mechanistic discovery. Integrating recent advances in ligand screening, particularly thermal shift assays, and contextualizing the library within the competitive landscape, it offers actionable guidance for researchers targeting complex biological pathways, including apoptosis and PI3K/Akt/mTOR signaling. The discussion highlights strategic workflows, protocol parameters, and the unique translational power of this resource, while acknowledging both maturity and limitations for cross-domain applications.

• G-15: A G Protein-Coupled Estrogen Receptor Antagonist in Ne

  2026-07-13

  G-15 enables precise dissection of GPR30-mediated pathways, uniquely supporting both cellular and in vivo models of estrogen signaling. Its selectivity and robust pharmacology streamline workflows in pain, neurobiology, and immune modulation, as demonstrated by its pivotal role in recent neuropathic pain research.

• Resolving Assay Challenges with Cy5 Goat Anti-Mouse IgG (H+L

  2026-07-13

  This article addresses practical workflow hurdles faced in cell-based immunoassays and demonstrates how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody (SKU K1210) from APExBIO offers proven solutions. Through scenario-driven analysis rooted in recent literature and validated protocols, researchers gain actionable insights into optimizing sensitivity, reproducibility, and reliability in mouse IgG detection.

• L. plantarum P101 Attenuates Alcoholic Steatosis via AMPK Pa

  2026-07-12

  This study demonstrates that Lactiplantibacillus plantarum P101 significantly reduces alcohol-induced hepatic lipid accumulation in mice by activating the AMPK signaling pathway. Using targeted AMPK inhibition, the research clarifies the mechanistic link between probiotic intervention, gut microbiota modulation, and hepatic metabolic regulation, providing an experimental foundation for future strategies in alcoholic fatty liver disease management.

• MAPK Regulators of ECM Internalisation Drive Cancer Invasion

  2026-07-10

  Martinez et al. (2024) developed a high-content screening assay to uncover novel kinase regulators of extracellular matrix (ECM) internalisation in invasive carcinoma cells. They identified the α2β1 integrin/p38 MAPK axis as a critical driver of ECM endocytosis and cell migration, with implications for understanding and targeting cancer invasiveness.

• High Viscosity Drives Chemoresistance via P-gp Upregulation

  2026-07-09

  This study reveals that high extracellular fluid viscosity in the tumor microenvironment promotes chemoresistance in cancer cells by upregulating P-glycoprotein (P-gp) through a mechanobiological signaling cascade. The findings highlight mechanical cues as critical regulators of drug resistance and suggest new avenues for overcoming transporter-mediated chemoresistance.

• Difloxacin HCl: Mechanistic Insights for Next-Generation Ant

  2026-07-09

  Explore the scientific foundation and innovative applications of Difloxacin HCl, a quinolone antimicrobial antibiotic, in advanced susceptibility testing and multidrug resistance research. This article uniquely bridges mechanistic understanding with assay optimization for research excellence.

• Docetaxel (SKU A4394): Practical Answers for Reliable Assays

  2026-07-08

  This article delivers scenario-driven, evidence-backed guidance for applying Docetaxel (SKU A4394) in cancer cell viability, proliferation, and cytotoxicity workflows. Drawing on peer-reviewed research and product data, it addresses common laboratory challenges and positions APExBIO's Docetaxel as a robust solution for reproducible oncology assays.

15168 records 1/1012 page Next 12345 下5页 Last page